SIRPα Suppresses Response to Therapeutic Antibodies by Nurse Like Cells From Chronic Lymphocytic Leukemia Patients

Targeted antibody therapies improve outcomes for chronic lymphocytic leukemia (CLL) patients. However, resistance often develops. We have previously shown that resistance to therapeutic antibodies, by monocyte derived macrophages (referred to as nurse like cells, NLCs), from CLL patients is characte...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yu-Chen Enya, Burgess, Melinda, Mapp, Sally, Mollee, Peter, Gill, Devinder, Blumenthal, Antje, Saunders, Nicholas A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859087/
https://www.ncbi.nlm.nih.gov/pubmed/33552071
http://dx.doi.org/10.3389/fimmu.2020.610523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859087/
https://www.ncbi.nlm.nih.gov/pubmed/33552071
http://dx.doi.org/10.3389/fimmu.2020.610523

Ejemplares similares